
pm et
summari compani largest pharmaci health care provid
price-to-earnings oper ep
risk assess reflect compani leadership
posit strong market share rel stabl
 retail drug industri off-set acquisition-integr
risk growth non-tradit competitor
past perform indic futur perform reli upon
analysi prepar equiti analyst
oct stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
et cfra reiter
lift target
ep estim
multipl near low end
rang persist
ep vs lower
estim lift ep
keep ep outlook
unchang quarter progress
mostli expect sale increas
billion same-stor
store sale increas quarter
driven consum health care beauti
care categori manag expect close
merger aetna prior thanksgiv
nov plan achiev two-year
synergi exce origin goal
million primarili come lower corpor
expens oper integr medic
store offer new program servic
run earli huang
feb ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
execut vice-president chief
offic gener
corpor overview health corpor oper one largest drug store chain
pharmaci benefit manag base revenu net incom store count drug store offer
prescript drug wide assort gener merchandis includ over-the-counter drug beauti product
cosmet film photo finish servic season merchandis greet card conveni
servic plan design administr formulari manag claim process two
revenu gener report segment pharmaci servic retail/ltc long-term care
market profil decemb oper retail locat
walk-in health care clinic lead pharmaci benefit manag million plan
member oper state district columbia puerto rico brazil decemb
compani store top drug store market fill billion
prescript billion fill retail/ltc segment account
 retail pharmaci market
pharmaci servic segment provid full rang pharmaci benefit manag pbm servic
includ oper mail order pharmaci specialti pharmaci medicar part servic
formulari manag discount drug purchas agreement busi gener billion
sale total compani sale exclud interseg elimin part
pharmaci servic segment specialti pharmaci busi oper retail specialti
pharmaci store specialti mail order pharmaci four mail servic pharmaci
retail/ltc segment revenu revenu compris pharmaci retail
segment revenu front store revenu retail revenu front
store categori includ over-the-count drug beauti product cosmet person
care product conveni food among product proprietari brand product account
approxim compani front store revenu also largest oper
retail health care clinic decemb oper retail health care clinic
state minuteclin name clinic diagnos treat minor health condit perform
health screen monitor chronic condit deliv vaccin compani open new
clinic
corpor strategi pharmaci servic busi strategi center provid innov tool
strategi well qualiti client servic help improv clinic outcom client plan
member assist better pharmaci manag overal health care cost aim
leverag expertis core pbm servic includ plan design offer administr
formulari manag medicar part servic mail order specialti pharmaci infus servic
diseas manag servic medic spend manag
one key retail pharmaci busi strategi technolog allow focu
constantli improv servic explor way provid person product offer
servic continu leverag digit tool empow custom patient make full
breadth health care pharmaci servic avail anytim anywher also continu
introduc digit tool make easier peopl save time money live healthier live
roll pay nationwid end-to-end mobil payment solut integr
payment prescript pick-up extracar loyalti program one spot checkout
impact major develop agre acquir third largest health insur
aetna aet total enterpris valu billion decemb believ combin
expect close second half make strateg sens provid greater
abil incentiv aet million health plan particip util caremark mail order system
retail store complet deal pend approv also elimin risk lose aet
busi revenu
decemb acquir pharmaci busi consist locat
in-stor health clinic approxim billion clinic purchas re-brand
minuteclin open new clinic within store end addit
plan develop five small-format store two-year period follow close
august acquir omnicar prescript drug servic provid long-term health
specialti healthcar industri total enterpris valu billion deal accret
reflect signific synergi revenu purchas addit improv oper effici
financi trend sale grew compound annual growth rate compound-annual-growth-rate billion
year end decemb adjust ep grew slightli higher compound-annual-growth-rate free cash
flow measur cash flow oper less capit expenditur billion lower
billion june low net debt total capit ratio
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
neutral sinc octob technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
servic provid fewer custom like
enrol insur plan start
fewer patient insur uncompens
care rate could rise hospit health
care facil lead lower profit
lower demand supplement health care
servic think
import watch mid-term elect
novemb health care appear
import topic among voter
year date septemb
versu increas
composit index
increas
fundament outlook health care
servic sub-industri next month
neutral sub-industri perform well
last quarter strength
 economi result lower
number uninsur individu better health
care coverag higher employ strong
economi also led shortag labor
health care servic long run
think health care servic
continu benefit modestli age
popul increas focu
prevent care offset posit
trend continu pressur reduc
cost health care system
outlook pharmaci benefit manag pbm
neutral see continu consolid
third-parti payer sourc mount
pressur pbm pbm hurt recent
lower level drug price inflat
partial allevi high util
result pbm merg insur
off-set pressur notabl
acquir aet ci acquir esrx
see pbm continu benefit
numer brand drug lost patent
protect recent year increas gener
drug usag typic result higher
profit compani
although republican administr
 difficulti repeal
stop medicaid expans think
repeal question
recent on-going lawsuit texa
question constitution
senat also fail multipl time
gather enough vote pass variou repeal
replac bill howev republican
success elimin individu
mandat passag tax cut
job act decemb see
develop neg health care
base index
five-year market price perform
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
signific rise drug price increas rebat
demand pbm hand blame drug manufactur state
need higher rebat discount higher drug list price fda
commission gottlieb indic may examin rebat pbm receiv
potenti kickback potenti medicar negoti tabl
expect share drug firm react favor potenti downward pressur
et cfra keep hold opinion share aetna inc
keep target price base agreed-upon
acquisit term cash share
aet share note final offer price depend share
price close aet expect deal close second half
separ ep vs ahead estim partli
aid tax rate year ago due tax reform sale
rose due membership growth aet medicar product medicar
membership increas aet member march
year ago mainli due declin medicaid
member aet medic benefit ratio improv
partli due reinstat health insur fee /jeffrey loo
analyst research note compani news
et cfra reiter strong buy opinion share
health corpor lift target
ep estim multipl near
low end rang persist industry-wid drug
reimburs pressur ep vs lower
estim lift ep keep ep
outlook unchang quarter progress mostli expect
sale increas billion same-stor prescript volum grew
front store store sale increas quarter driven
consum health care beauti care categori manag expect close
merger aetna prior thanksgiv nov plan
achiev two-year synergi exce origin goal million
primarili come lower corpor expens oper integr
medic cost reduct expect first concept store offer new
program servic run earli /kevin huang cfa
buy buy lift target
next-twelve-month ep estim rais valuat
see certain profit futur yesterday
doj approv cvs-aet merger multipl still lower end
five-year forward pe rang uncertain
drug price environ among pressur share dip midday
thursday primarili news plan departur arrang cfo
combin entiti shawn guertin aet current cfo guertin seen
key person ensur smooth transit integr two entiti
intend resign june person famili reason despit
loss guertin still see signific strateg valu combin entiti
corpor maintain target
ep estim multipl near low end
rang see valuat still hurt intens industri
drug reimburs pressur weak in-stor traffic trend ep
vs higher estim maintain ep
rais ep sale increas
billion same-stor prescript volum grew took
billion goodwil impair charg quarter relat long-term
care busi omnicar pressur facil client
earn call manag highlight drug rebat would like
account million ep opinion
reduc risk drug price chang could result on-going
discuss trump administr pharmaceut manufactur
et cfra keep buy opinion share
corpor take
larger role on-line pharmaci space agre acquir on-line retail
pillpack today acquisit could provid toehold pharmaci
benefit manag pbm retail drug space howev think
signific size scale provid substanti barrier overcom
potenti disrupt establish industri could take
time believ market initi reaction pillpack
acquisit agreement may overblown /kevin huang cfa
et cfra keep neutral outlook
sub-industri presid trump expect unveil plan
tackl high drug price today believ like focu two area
rebat pharmaci benefit manag pbm get drug firm
discount medicar get scenario believ trump push
portion rebat pbm receiv medicar discount pass
patient anticip trump propos allow medicar negoti
drug price drug firm ban law drug firm blame pbm
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
